![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 25, 18745-18750, June 23, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute of Physiology, Ludwig Maximilians University
Munich, 80336 Munich, Germany and the § Institute of
Pathophysiology, University of Halle, 06097 Halle, Germany
Received for publication, January 5, 2000, and in revised form, March 2, 2000
Superoxide anions impair nitric oxide-mediated
responses and are involved in the development of hypertensive vascular
hypertrophy. The regulation of their production in the vascular system
is, however, poorly understood. We investigated whether changes in membrane potential that occur in hypertensive vessels modulate endothelial superoxide production. In cultured human umbilical vein
endothelial cells, changes in membrane potential were induced by high
potassium buffer, the non-selective potassium channel blocker
tetrabutylammonium chloride (1 mM), and the
non-selective cation ionophore gramicidin (1 µM).
Superoxide formation was significantly elevated to a similar degree by
all three treatments (by ~60%, n = 23, p < 0.01), whereas hyperpolarization by the
KATP channel activator Hoe234 (1 µM) significantly decreased superoxide formation. Depolarization also induced an increased tyrosine phosphorylation of
several not yet identified proteins (90-110 kDa) and resulted in a
significant increase in membrane association of the small G-protein
Rac. Accordingly, the Rac inhibitor Clostridium
difficile toxin B blocked the effects of depolarization on
superoxide formation. The tyrosine kinase inhibitor genistein (30 µM, n = 15) abolished depolarization-induced superoxide formation and also prevented depolarization-induced Rac translocation associated with it. It is
concluded that depolarization is an important stimulus of endothelial superoxide production, which involves a tyrosine
phosphorylation-dependent translocation of the small G-protein Rac.
An increased production of vascular superoxide anions causes an
impairment of NO-dependent vasodilation and plays an
important pathophysiologic role for the initiation and progression of
atherosclerosis and hypertension (1). Superoxide anions are also
involved in promoting smooth muscle proliferation and vessel restenosis
after angioplasty (2, 3). They might, however, also have a physiologic role termed "redox priming" in modulating cytokine receptors (4). Although vascular smooth muscle (5) and adventitial cells (6) are able
to produce superoxides, endothelium-derived superoxides were shown to
play the predominant pathophysiologic role in cardiovascular disorders
such as hyperlipidemia (7).
Recent studies suggest that a neutrophil-type NAD(P)H oxidase is the
main source of cellular superoxide generation in endothelial cells (8,
9). This multicomponent enzyme includes the membrane-bound cytochrome
b558 (p22phox and
gp91phox) and cytosolic proteins
(p47phox, p67phox,
Rac1/2, and p40phox) that translocate to the
plasma membrane during stimulation to form a catalytically active
oxidase (10, 11). The expression of these subunits in endothelial cells
has been demonstrated (12, 13) although the regulation of the whole
enzyme complex in endothelial cells is not clear. In leukocytes a
number of signaling pathways have been shown to be involved in
activation of the enzyme. Protein kinase C is known to phosphorylate
p47phox at several serine residues during
NAD(P)H oxidase activation, thereby enabling interaction with
cytochrome b558 (10, 14). Alternatively, protein
kinase C-independent activation of NAD(P)H oxidase involves tyrosine
phosphorylation-dependent steps (15-18). In both pathways,
the translocation of the small GTP-binding protein Rac1/2 could be an
integral step because it is required in leukocytes for the full
activation of the respiratory burst (19, 20).
In endothelial cells, the mechanisms involved in activation of NAD(P)H
oxidase have not yet been studied and may depend on the endothelial
stimulus. Recently, Al-Mehdi et al. (21) reported that in
isolated perfused lungs the production of reactive oxygen species was
significantly increased in the presence of membrane-depolarizing potassium buffer. This may also hold true for other (patho-)physiologic conditions because stimulation of vascular smooth muscle cells frequently goes along with acute changes in membrane potential. Moreover, vascular smooth muscle of hypertensive rats has been shown to
be chronically depolarized (22). These acute and chronic changes of
smooth muscle membrane potential can be conducted to the endothelial
layer via heterologous gap junctions (23, 24). Consistent with the
hypothesis of a pressure-induced depolarization, isolated arterioles
exposed to high intravascular pressure for 30 min exhibited increased
vascular superoxide formation (25).
Little is known, however, about the cellular mechanisms that could lead
to superoxide generation after depolarization of the cell membrane. In
particular it is not clear whether the above mentioned signaling
pathways are activated or whether there is a direct voltage-sensitive
activation mechanism of the enzyme itself as suggested by the
structural homology between NAD(P)H-dependent oxidoreductases and a shaker potassium channel (26). We therefore first
studied whether depolarization induces an activation of endothelial
superoxide formation. Second, we analyzed whether this effect is
mediated by protein kinase C or tyrosine
phosphorylation-dependent pathways. Moreover, we tested
whether depolarization would lead to an increased membrane
translocation of Rac, which would make a direct
voltage-dependent activation of the enzyme unlikely.
Cell Culture--
Human umbilical vein endothelial cells were
isolated from freshly obtained human umbilical veins as described (27).
The cells were maintained in Medium 199 supplemented with 16% fetal calf serum and 20% endothelial growth medium (Promocell, Heidelberg, Germany). The cells used for experiments were in the 1-3 subpassage. The protein content of the samples was measured by the method of
Bradford (28).
Membrane Potential--
For the measurements of the membrane
potential the fluorescent dye bis-[1,3-dibutylbarbituric
acid]trimethineoxonol
(bis-oxonol)1 was used as an
indicator of changes of membrane potential. This dye has been used
previously for determination of changes in membrane potential of
endothelial cells (29). Human umbilical vein endothelial cells cultured
on coverslips were preincubated with bis-oxonol (100 nM) in
modified Tyrode's buffer (135 mM NaCl, 2.7 mM
KCl, 1.8 mM CaCl2, 0.49 mM
MgCl2, 0.28 mM NaH2PO4,
5.5 mM glucose, 20 mM HEPES) for 30 min to
equilibrate the cells with the dye and transferred into a perfusion
chamber. The cells were continuously superfused with modified Tyrode's
buffer containing bis-oxonol (0.5 ml/min). The fluorescence intensity
(excitation, 488 nm; emission, >515 nm) was recorded every 20 s
using a confocal microscope (Zeiss LSM 410). The fluorescence
intensities were calibrated in terms of changes in membrane potential
using the cationic ionophore gramicidin in the presence of different
potassium concentrations according to Langheinrich and Daut (30).
Superoxide Production--
Superoxide formation was determined
by the cytochrome c assay. Endothelial cells were incubated
in a modified Tyrode's buffer containing 40 µM
cytochrome c with or without superoxide dismutase (200 units/ml). After 30-60 min the supernatant was removed, and the
reduction of cytochrome c was measured at 550 nm (Ultrospec 2000, Amersham Pharmacia Biotech). The superoxide-dependent
part of cytochrome c reduction was calculated from the
difference in absorbance between samples incubated with or without
superoxide dismutase ( Tyrosine Phosphorylation--
Endothelial cells were suspended
in ice-cold lysis buffer (phosphate-buffered saline, 1% Triton X-100,
1 mM EDTA, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 10 µM phenylmethylsulfonyl fluoride, 2 mM
orthovanadate, 10 mM NaF, pH 7.0) and further disrupted by passing them five times through a 29-gauge needle. The lysates were
centrifuged (10,000 × g for 5 min), and the
supernatants were used for experiments. Proteins were separated via
SDS-polyacrylamide gel electrophoresis following standard procedures
and transferred onto a nitrocellulose membrane. After incubation with
the phosphotyrosine antibody (Upstate Biotechnology, Lake Placid, NY)
and a secondary antibody linked to alkaline phosphatase, tyrosine
phosphorylation was detected with the nitro blue
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate system.
Rac Translocation--
Endothelial cells were lysed as described
above in ice-cold lysed buffer and centrifuged (500 × g for 5 min) to separate unbroken cells and nuclei. After
centrifugation of the supernatant (22,000 × g for 90 min, 4 °C) the membrane fraction was used. After SDS-polyacrylamide gel electrophoresis the proteins were transferred onto polyvinylidene difluoride membranes (Schleicher & Schüll). Equal protein loading was confirmed by reprobing the membrane with anti-actin (data not
shown). The amount of membrane-located Rac was determined using a
specific antibody against Rac (Upstate Biotechnology). It recognizes
human Rac1 and Rac2. The antibody was used at a concentration of 1 µg/ml dissolved in the blocking buffer (20% horse serum, 3%
albumin). The secondary antibody (Calbiochem) was linked to horseradish
peroxidase. The band intensities for Rac were determined using a
videodensitometric system (Bio-Rad).
p22phox/gp91phox Expression--
The
expression of the NAD(P)H oxidase subunits
p22phox and gp91phox was
determined either by semiquantitative (p22phox)
or standard calibrated competitive (gp91phox)
reverse transcription-polymerase chain reaction. Total RNA was isolated
using the single step TRI reagent as described in the product protocol
(Life Technologies, Inc.). 1 µg of the total RNA was used for the
reverse transcription-polymerase chain reaction, which was performed
with the Titan reverse transcription-polymerase chain reaction system
(Roche Molecular Biochemicals). The primer sequence used in this study
for the p22phox is described by Jones et
al. (13) (forward, GTT TGT GTG CCT GCT GGA GT; reverse, TGG GCG
GCT GCT TGA TGG T). As internal control, the expression of
glyceraldehyde-3-phosphate dehydrogenase was used. For
gp91phox mRNA expression equal amounts of
total RNA were incubated in separate reactions with defined amounts of
gp91phox standard cRNA molecules and
subsequently reverse transcribed into cDNA using random hexamer
primers and SuperScript II RNase H Materials--
Hoe234 was a gift from Dr. Hansen (Aventis,
Frankfurt, Germany). Clostridium difficile toxin
B was provided by Dr. M. Essler, University of Munich. Superoxide
dismutase was from Roche Molecular Biochemicals. Endothelial growth
medium was purchased from PromoCell, sodium orthovanadate was purchased
from Alexis Biochemicals, and bis-oxonol was purchased from Molecular
Probes. All other substances were from Sigma.
Statistical Analysis--
Statistical comparisons with and
without treatment within the same experimental group were performed
using the Wilcoxon signed rank test for paired observations.
Differences were considered as significant at an error probability of
p < 0.05. For descriptive means all results are
expressed as means ± S.E.
Measurements of Changes in Endothelial Membrane Potential--
The
resting membrane potential of human umbilical vein endothelial cells
was found to be Effects of Changes in Membrane Potential on Endothelial Superoxide
Generation--
The effect of membrane depolarization on endothelial
superoxide generation is shown in Fig.
2A. Superoxide formation was
significantly elevated by high potassium buffer (90 mM),
gramicidin (1 µM), and TBA (1 mM) to a
similar degree (0.17 ± 0.03 versus 2.9 ± 0.03, 0.27 ± 0.4, and 0.28 ± 0.4 nmol of superoxide/min/mg of
protein, respectively; n = 23, p < 0.01). In contrast, hyperpolarization by Hoe234 (1 µM)
led to a significant decrease in superoxide formation (Fig.
2B, n = 11, p < 0.01). This
decrease was prevented by preincubation of the cells with the
KATP channel blocker glibenclamide (10 µM, n = 7, p < 0.05).
Effect of Depolarization on NAD(P)H-dependent
Superoxide Formation--
To examine whether a neutrophil-type NAD(P)H
oxidase is involved in depolarization-induced superoxide formation, in
a separate series of experiments, NADH-induced superoxide formation was
examined in lysates of endothelial cells. This method allows the
assessment of the amount of assembled and activated enzyme complexes. A
depolarization for 1 h by high potassium buffer (90 mM), gramicidin (1 µM), and TBA (1 mM) resulted in a significant increase in
NADH-dependent superoxide formation (Fig.
3A; 1.68 ± 0.2 versus 3.22 ± 0.36, 3.46 ± 0.54, and 2.87 ± 0.41 nmol of superoxide/min/mg of protein, respectively;
n = 18). Accordingly, in intact cells the NAD(P)H oxidase blocker diphenyleniodonium chloride (DPI, 30 µM)
significantly attenuated depolarization-induced superoxide
formation by 76.2% (n = 10, p < 0.05, Fig. 3B).
Effects of Depolarization on the Expression of the NAD(P)H Oxidase
Subunits--
Fig. 4 demonstrates the
expression of the NAD(P)H oxidase subunits
p22phox and gp91phox in
human umbilical vein endothelial cells. Depolarization for 1 and 6 h with high potassium buffer (90 mM) did not affect the expression of these two components of the endothelial NAD(P)H oxidase
(n = 3).
Role of Tyrosine Phosphorylation in Depolarization-induced
Superoxide Generation--
We examined whether depolarization-induced
activation of endothelial superoxide formation involves tyrosine
phosphorylation-dependent steps or activation of protein
kinase C. Pretreatment of the cells with the protein kinase C inhibitor
staurosporine (100 nM) did not significantly alter
depolarization-induced superoxide production (n = 12, data not shown). In contrast, the tyrosine kinase blocker genistein (30 µM, n = 15) blocked the superoxide
production elicited by high potassium buffer (90 mM),
gramicidin (1 µM), and TBA (1 mM, Fig.
5) without altering the membrane
potassium-induced depolarization (+11.4 ± 1.8 mV,
n = 3). Daidzein, an inactive analog of genistein, had
no effects on superoxide production. We also examined directly whether
depolarization modulates cellular tyrosine phosphorylation. Membrane
depolarization (30 min) induced an increased tyrosine phosphorylation
of several not yet identified 90-110-kDa proteins (Fig.
6).
Role of Rac in Depolarization-induced Superoxide
Production--
Because the membrane association of Rac is necessary
for a full activation of NAD(P)H oxidase in leukocytes, we studied
whether depolarization leads to an enhanced membrane translocation of Rac. Depolarization for 30 min resulted in a significant increase in
membrane-associated Rac (Fig. 7,
n = 11). Preincubation with genistein (30 µM) prevented depolarization-induced Rac translocation as
well as superoxide formation. Genistein-treated cells did not exhibit
in the resting state a significantly reduced membrane association of
Rac (Fig. 7). Treatment with the Rac
inhibitor C. difficile toxin B (0.5 ng/ml) also
completely blocked the increase of endothelial superoxide formation
following depolarization (Fig. 8, n = 7; *,
p < 0.05 versus control; #,
p < 0.05 versus depolarization). C. difficile toxin B did not affect the potassium-induced membrane depolarization (+13.4 ± 5.4 mV, n = 3).
The results show that membrane depolarization induces an enhanced
generation of superoxide in endothelial cells. This is because of the
activation of a neutrophil-type NAD(P)H oxidase that involves a
tyrosine phosphorylation-dependent membrane translocation
of the small G-protein Rac. At the same time, these results make a
conceivable direct voltage-dependent activation of this
enzyme unlikely.
In neutrophils, the membrane translocation of the small G-protein Rac
is known to be closely related to an activation of NAD(P)H oxidase and
to be essential for full activation of the respiratory burst in
phagocytes (19, 20, 31, 32). The translocation occurs in response to
different stimuli such as protein kinase C activators or
N-formyl-methionyl-leucyl-phenylalanine (15, 32). In
vascular cells, Rac also seems to be of crucial importance for the
production of reactive oxygen species induced by hypoxia/re-oxygenation or by elevated shear stress (33, 34). In support of the concept of a
central role for Rac, depolarization-induced superoxide formation was
also abolished following Rac inactivation by toxin B in this study. It
is still not clear how Rac affects the activity of NAD(P)H oxidase.
Dorseuil et al. (35) recently reported that the
translocation of Rac2 but not of the cytosolic NADPH oxidase subunits
p47phox or p67phox could
be inhibited by genistein in chemoattractant-stimulated human
neutrophils, which suggests that Rac may not control the assembly of
the enzyme but rather a distal step. This remains to be determined in
endothelial cells as well.
The translocation of Rac following tumor necrosis factor- In neutrophils, the respiratory burst is followed by a transient
depolarization that is clearly a consequence of the electrical gradient
induced by an outward flux of electrons (38, 39). Thus, this
burst-induced depolarization could be prevented by the NAD(P)H oxidase
inhibitor DPI, or this depolarization does not occur in neutrophils
from patients suffering from chronic granulomatous disease (40, 41). In
our experiments, however, depolarization preceded superoxide formation,
suggesting that a change in membrane potential was the initial step in
a signal cascade that involved tyrosine phosphorylation and Rac
translocation. The identical effects of structurally and
mechanistically different compounds used for cell depolarization on
superoxide formation imply that our observations were in fact due to
the modulating effects of these different compounds on the membrane
potential and not due to unspecific side effects. This implication is
further supported by the fact that membrane hyperpolarization by
opening KATP channels attenuated superoxide
production. This effect was not caused by an increased scavenging of
superoxides by the enhanced production of NO due to hyperpolarization
(42), because the effect was observed in the presence of a NO synthase
inhibitor. Similar findings with KATP channel
activation have also been described in neutrophils (43).
The structural homology between NAD(P)H-dependent
oxidoreductases and a shaker potassium channel (26) suggests one
mechanism by which depolarization could induce a direct
voltage-sensitive activation of the enzyme itself. Our results do not
support this mechanism because it should have bypassed Rac
translocation and the preceding tyrosine phosphorylation. The
stimulating effects of depolarization could also not be attributed to
an alteration in gene transcription enzyme constituents because a long
term depolarization (1 and 6 h) did not alter the expression of
the NAD(P)H oxidase subunits p22phox and
gp91phox. Other investigators, however, observed
an enhanced expression of these components in aortas derived from
angiotensin II-treated rats, suggesting that an activation of the renin
angiotensin system has additional effects as compared with an
alteration in membrane potential (44).
In conclusion, membrane depolarization results in increased endothelial
superoxide formation, which is probably due to an activation of an
NAD(P)H-dependent oxidase. A tyrosine
phosphorylation-dependent translocation of the small G-protein
Rac is involved in these processes, which may represent a new and
interesting target for therapeutic control of endothelial superoxide
production. Because many vasoactive compounds go along with transient
changes of endothelial membrane potential (45), the mechanisms
described here may represent a basic component in the control of
vascular superoxide production.
We thank D. Goessel and E. Musiol for
excellent technical assistance and Paula H. Sohn for helpful discussions.
*
This study was supported by Deutsche Forschungsgemeinschaft
(553/B2). This paper contains part of the doctoral thesis of Matthias Keller to be submitted to the medical faculty of the
Ludwig-Maximilians-University Munich.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, April 10, 2000, DOI 10.1074/jbc.M000026200
The abbreviations used are:
bis-oxonol, bis-[1,3-dibutylbarbituric acid]trimethineoxonol;
TBA, tetrabutylammonium chloride;
DPI, diphenyleniodonium chloride.
The Small G-protein Rac Mediates Depolarization-induced
Superoxide Formation in Human Endothelial Cells*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
550 nmol/liter = 21.1 mM
1
cm
1). All measurements of superoxide
formation were performed in the presence of the NO synthase inhibitor
NG-nitro-L-arginine (30 µM) to prevent modulating effects of NO. In separate
experiments, the NADH-induced superoxide production in cell lysates was
measured. The cells were suspended in lysis buffer (20 mM
potassium phosphate buffer containing 1 mM EDTA, 5 µg/ml
aprotinin, 2 µg/ml pepstatin, 2 µg/ml leupeptin, pH 7.0). In 400 µl of phosphate-buffered saline (160 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4,
1.5 mM KH2PO4, pH 7.40) containing
aliquots of the samples (5 µg protein content) with or without
superoxide dismutase (200 units/ml), NADH (100 µM) was
added, and the superoxide dismutase-dependent reduction of
cytochrome c (40 µM) was determined for 15 min
as described.
reverse transcriptase
(Life Technologies, Inc.). Afterward, 25% of each reverse
transcription reaction was amplified in separate reactions with
gp91phox primers (sense, 5'-GCT GTT CAA TGC TTG
TGG CT-3'; antisense, 5'-TCT CCT CAT CAT GGT GCA CA-3').
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
47.1 ± 1.8 mV (n = 23).
Treatment by 90 mM potassium buffer, the non-selective
potassium channel blocker tetrabutylammonium chloride (TBA, 1 mM), and the non-selective cation ionophore gramicidin (1 µM) elicited nearly the same magnitude of depolarization,
whereas the KATP channel opener Hoe234 (1 µM) significantly hyperpolarized the cells (Fig.
1). The compounds immediately changed the
membrane potential, but a new steady state potential was achieved only
after 7-10 min. The latter result was due to the low flow rate in the
perfusion chamber; the low flow rate was used to avoid flow- or
pressure-dependent changes of the membrane potential. The
new steady state potential remained constant over the whole perfusion
time with a depolarizing agent.

View larger version (17K):
[in a new window]
Fig. 1.
Measurements of endothelial membrane
potential. Endothelial cells were continuously superfused with
modified Tyrode's buffer containing the potential-sensitive dye
bis-oxonol (100 nM). The changes in fluorescence
intensities were recorded after addition of compounds that modulate the
membrane potential (n = 3). The fluorescence
intensities were calibrated in the presence of different potassium
concentrations as described under "Experimental Procedures."

View larger version (13K):
[in a new window]
Fig. 2.
Depolarization increases endothelial
superoxide formation (A), and
hyperpolarization attenuates endothelial superoxide formation
(B). A, endothelial cells were
depolarized by high potassium buffer (90 mM), the cation
ionophore gramicidin (1 µM), and the potassium channel
blocker TBA (1 mM), and superoxide formation was measured
using the cytochrome c assay (n = 23; **,
p < 0.01 versus control). B,
hyperpolarization-dependent superoxide formation was
determined after addition of the KATP channel
opener Hoe234 (1 µM; n = 11; **,
p < 0.01 versus control). In some
experiments the cells were preincubated with the
KATP channel blocker glibenclamide
(Glibenclam.; 10 µM; n = 7; #,
p < 0.05 versus Hoe234).

View larger version (12K):
[in a new window]
Fig. 3.
Depolarization increases
NADH-dependent superoxide formation (A),
and the NAD(P)H oxidase blocker DPI inhibits depolarization-induced
superoxide formation (B). A, after
depolarization of endothelial cells by high potassium buffer (90 mM), the cation ionophore gramicidin (1 µM),
and the potassium channel blocker TBA (1 mM), the cells
were lysed as described under "Experimental Procedures." In
aliquots of the lysates (5 µg protein content), NADH (100 µM)-dependent superoxide production was
measured using the cytochrome c method (n = 18; *, p < 0.05 versus control; **,
p < 0.01 versus control). B,
endothelial cells were depolarized (depol.) by high
potassium buffer (90 mM), and superoxide formation was
measured using the cytochrome c assay in the presence or
absence of the flavoprotein inhibitor DPI (n = 10; *,
p < 0.05 versus control, #,
p < 0.05 versus high potassium buffer). DPI
was preincubated for 30 min.

View larger version (49K):
[in a new window]
Fig. 4.
Expression of NAD(P)H oxidase subunits in
endothelial cells. Endothelial cells were depolarized by high
potassium buffer (90 mM) for 1 or 6 h. The expression
of the NAD(P)H oxidase subunits p22phox and
gp91phox was analyzed by reverse
transcription-polymerase chain reaction as described under
"Experimental Procedures" (n = 3). The polymerase
chain reaction products were assessed by ethidium bromide staining in
1% agarose gel.

View larger version (33K):
[in a new window]
Fig. 5.
The tyrosine kinase blocker genistein
inhibits depolarization-induced superoxide formation. Endothelial
cells were depolarized by high potassium buffer (90 mM),
the cation ionophore gramicidin (1 µM), and the potassium
channel blocker TBA (1 mM), and superoxide formation was
measured in the presence (n = 23; **, p < 0.01 versus control) or absence of the tyrosine kinase
inhibitor genistein (30 µM, n = 15, not
significant) using the cytochrome c assay.

View larger version (70K):
[in a new window]
Fig. 6.
Depolarization-induced tyrosine
phosphorylation in endothelial cells. After depolarization
by high potassium buffer (90 mM), the cation ionophore
gramicidin (1 µM), and the potassium channel blocker TBA
(1 mM), endothelial cells were lysed, separated using
SDS-polyacrylamide gel electrophoresis, and blotted on nitrocellulose
membranes. The membranes were probed with an antibody specific for
tyrosine phosphorylation (n = 3). Membrane
depolarization induced an increased tyrosine phosphorylation of several
not yet identified 90-110-kDa proteins.

View larger version (29K):
[in a new window]
Fig. 7.
Depolarization-induced membrane translocation
of Rac. Top panel, after membrane depolarization
endothelial cells were lysed, and the plasma membrane fraction was
separated via SDS-polyacrylamide gel electrophoresis. After blotting on
polyvinylidene difluoride membranes, the plasma membrane-located Rac
was determined using an antibody specific for Rac (n = 11). Genistein alone did not affect the amount of the membrane-bound
Rac (n = 3). The bottom panel shows the
densitometric analysis of the Rac staining (*, p < 0.05 versus control; #, < 0.05 versus
depolarization (depol.)).

View larger version (34K):
[in a new window]
Fig. 8.
Inactivation of Rac abolishes
depolarization-induced superoxide formation. After depolarization
with the cation ionophore gramicidin (1 µM) or the
potassium channel blocker TBA (1 mM), superoxide formation
was determined using the cytochrome c assay. In separate
experiments superoxide production was measured in the presence of the
Rac inhibitor C. difficile toxin B (0.5 ng/ml;
n = 7; *, p < 0.05 versus
control; #, p < 0.05 versus
depolarization).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
treatment
in neutrophils was sensitive to the tyrosine kinase inhibitor genistein
but not to protein kinase C blockade (15). Activation of the neutrophil
NAD(P)H oxidase involves tyrosine phosphorylation although neither the
phosphorylation site nor the involvement of tyrosine kinase has yet
been identified (15-18). Thannickal et al. (36) reported
recently that tyrosine phosphorylation of 103- and 115-kDa proteins
mediates hydrogen peroxide production in lung fibroblasts by a
membrane-bound NADH oxidase. In agreement with this observation in
neutrophils, we found that depolarization-induced translocation of Rac
(which was followed by enhanced superoxide formation) was inhibited by
the tyrosine kinase inhibitor genistein but not by the protein kinase C
blocker staurosporine. This indicates that Rac is activated in a
similar way in both cell types. Actions of genistein not related to
tyrosine phosphorylation, such as scavenging of superoxides (37), were
excluded because daidzein, a functional inactive analog of genistein,
had no effect, a result similar to that observed in our previous
studies (27). We also found an enhanced tyrosine phosphorylation of
several proteins (90-110 kDa) after depolarization, of which the
functional significance remains to be elucidated.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Institute of
Physiology, Ludwig-Maximilians University Munich, Schillerstrasse 44, Munich 80336, Germany. Tel.: 49 89 5996384; Fax: 49 89 5996378; E-mail:
sohn@lrz.uni-muenchen.de.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Grunfeld, S.,
Hamilton, C. A.,
Mesaros, S.,
McClain, S. W.,
Dominiczak, A. F.,
Bohr, D. F.,
and Malinski, T.
(1995)
Hypertension
26,
854-857
2.
Wolin, M. S.
(1996)
Microcirculation
3,
1-17
3.
Li, P. F.,
Dietz, R.,
and von Harsdorf, R.
(1997)
Circulation
96,
3602-3609
4.
Schmid, E.,
Hotz, W. A.,
Hacj, V.,
and Droge, W.
(1999)
FASEB J.
13,
1491-1500
5.
Griendling, K. K.,
Minieri, C. A.,
Ollerenshaw, J. D.,
and Alexander, R. W.
(1994)
Circ. Res.
74,
1141-1148
6.
Pagano, P. J.,
Chanock, S. J.,
Siwik, D. A.,
Colucci, W. S.,
and Clark, J. K.
(1998)
Hypertension
32,
331-337
7.
Ohara, Y.,
Peterson, T. E.,
and Harrison, D. G.
(1993)
J. Clin. Invest.
91,
2546-2551
8.
Mohazzab, K. M.-H.,
Kaminski, P. M.,
and Wolin, M. S.
(1997)
Circulation
96,
614-620
9.
Bauersachs, J.,
Bouloumie, A.,
Fraccarollo, D.,
Hu, K.,
Busse, R.,
and Ertl, G.
(1999)
Circulation
100,
292-298
10.
Chanock, S. J.,
el Benna, J.,
Smith, R. M.,
and Babior, B. M.
(1994)
J. Biol. Chem.
269,
24519-24522
11.
Cross, A. R.,
Erickson, R. W.,
and Curnutte, J. T.
(1999)
Biochem. J.
341,
251-255
12.
Bayraktutan, U.,
Draper, N.,
Lang, D.,
and Shah, A. M.
(1998)
Cardiovasc. Res.
38,
256-262
13.
Jones, S. A.,
O'Donnell, V. B.,
Wood, J. D.,
Broughton, J. P.,
Hughes, E. J.,
and Jones, O. T.
(1996)
Am. J. Physiol.
271,
H1626-H1634
14.
el Benna, J.,
Faust, L. P.,
and Babior, B. M.
(1994)
J. Biol. Chem.
269,
23431-23436
15.
Dusi, S.,
Della, B. V.,
Donini, M.,
Nadalini, K. A.,
and Rossi, F.
(1996)
J. Immunol.
157,
4615-4623
16.
Mitsuyama, T.,
Takeshige, K.,
and Minakami, S.
(1993)
FEBS Lett.
322,
280-284
17.
Yaname, H.,
Fukunaga, T.,
Nigorikawa, K.,
Okamura, N.,
and Ishibashi, S.
(1999)
Arch. Biochem. Biophys.
361,
1-6
18.
Kawakami, N.,
Takemasa, H.,
Yamaguchi, T.,
Hayakawa, T.,
Shimohama, S.,
and Fujimoto, S.
(1998)
Arch. Biochem. Biophys.
349,
89-94
19.
Kreck, M. L.,
Freeman, J. L.,
Abo, A.,
and Lambeth, J. D.
(1996)
Biochemistry
35,
15683-15692
20.
Quinn, M. T.,
Evans, T.,
Loetterle, L. R.,
Jesaitis, A. J.,
and Bokoch, G. M.
(1993)
J. Biol. Chem.
268,
20983-20987
21.
Al-Mehdi, A. B.,
Zhao, G.,
Dodia, C.,
Tozawa, K.,
Costa, K.,
Muzykantov, V.,
Ross, C.,
Blecha, F.,
Dinauer, M.,
and Fisher, A. B.
(1998)
Circ. Res.
83,
730-737
22.
Martens, J. R.,
and Gelband, C. H.
(1996)
Circ. Res.
79,
295-301
23.
Beny, J. L.,
and Pacicca, C.
(1994)
Am. J. Physiol.
266,
H1465-H1472
24.
Marchenko, S. M.,
and Sage, S. O.
(1994)
Am. J. Physiol.
267,
H804-H811
25.
Huang, A.,
Sun, D.,
Kaley, G.,
and Koller, A.
(1998)
Circ. Res.
83,
960-965
26.
Gulbis, J. M.,
Mann, S.,
and MacKinnon, R.
(1999)
Cell
97,
943-952
27.
Sohn, H. Y.,
Gloe, T.,
Keller, M.,
Schoenafinger, K.,
and Pohl, U.
(1999)
J. Vasc. Res.
36,
456-464
28.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
29.
He, P.,
and Curry, F. E.
(1995)
Microvasc. Res.
50,
183-198
30.
Langheinrich, U.,
and Daut, J.
(1997)
J. Physiol. (Lond.)
502,
397-408
31.
Irani, K.,
and Goldschmidt, C. P.
(1998)
Biochem. Pharmacol.
55,
1339-1346
32.
Diekmann, D.,
Abo, A.,
Johnston, C.,
Segal, A. W.,
and Hall, A.
(1994)
Science
265,
531-533
33.
Kim, K. S.,
Takeda, K.,
Sethi, R.,
Pracyk, J. B.,
Tanaka, K.,
Zhou, Y. F., Yu, Z. X.,
Ferrans, V. J.,
Bruder, J. T.,
Kovesdi, I.,
Irani, K.,
Goldschmidt, C. P.,
and Finkel, T.
(1998)
J. Clin. Invest.
101,
1821-1826
34.
Yeh, L. H.,
Park, Y. J.,
Hansalia, R. J.,
Ahmed, I. S.,
Deshpande, S. S.,
Goldschmidt-Clermont, P. J.,
Irani, K.,
and Alevriadou, B. R.
(1999)
Am. J. Physiol.
276,
C838-C847
35.
Dorseuil, O.,
Quinn, M. T.,
and Bokoch, G. M.
(1995)
J. Leukocyte Biol.
58,
108-113
36.
Thannickal, V. J.,
Aldweib, K. D.,
and Fanburg, B. L.
(1998)
J. Biol. Chem.
273,
23611-23615
37.
Ruiz, L. M.,
Mohan, A. R.,
Paganga, G.,
Miller, N. J.,
Bolwell, G. P.,
and Rice, E. C.
(1997)
Free Radic. Res.
26,
63-70
38.
Lukacs, G. L.,
Kapus, A.,
Nanda, A.,
Romanek, R.,
and Grinstein, S.
(1993)
Am. J. Physiol.
265,
C3-C14
39.
Gamaley, I. A.,
Kirpichnikova, K. M.,
and Klyubin, I. V.
(1998)
Free Radic. Biol. Med.
24,
168-174
40.
Henderson, L. M.,
Chappell, J. B.,
and Jones, O. T.
(1987)
Biochem. J.
246,
325-329
41.
Whitin, J. C.,
Chapman, C. E.,
Simons, E. R.,
Chovaniec, M. E.,
and Cohen, H. J.
(1980)
J. Biol. Chem.
255,
1874-1878
42.
Luckhoff, A.,
and Busse, R.
(1990)
Naunyn-Schmiedeberg's Arch. Pharmacol.
342,
94-99
43.
Pieper, G. M.,
and Gross, G. J.
(1992)
Immunopharmacology
23,
191-197
44.
Fukui, T.,
Ishizaka, N.,
Rajagopalan, S.,
Laursen, J. B.,
Capers, Q.,
Taylor, W. R.,
Harrison, D. G.,
deLeon, H.,
Wilcox, J. N.,
and Griendling, K. K.
(1997)
Circ. Res.
80,
45-51
45.
Mehrke, G.,
Pohl, U.,
and Daut, J.
(1991)
J. Physiol. (Lond.)
439,
277-299
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
B. Fuhrman, J. Khateeb, M. Shiner, O. Nitzan, R. Karry, N. Volkova, and M. Aviram Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1361 - 1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kido, K. Ando, M. L. Onozato, A. Tojo, M. Yoshikawa, T. Ogita, and T. Fujita Protective Effect of Dietary Potassium Against Vascular Injury in Salt-Sensitive Hypertension Hypertension, February 1, 2008; 51(2): 225 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sanchez, M. Escobar, Z. Pedrozo, P. Macho, R. Domenech, S. Hartel, C. Hidalgo, and P. Donoso Exercise and tachycardia increase NADPH oxidase and ryanodine receptor-2 activity: possible role in cardioprotection Cardiovasc Res, January 15, 2008; 77(2): 380 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kahles, P. Luedike, M. Endres, H.-J. Galla, H. Steinmetz, R. Busse, T. Neumann-Haefelin, and R. P. Brandes NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke Stroke, November 1, 2007; 38(11): 3000 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, J. L. Garvin, Y. Ren, P. J. Pagano, and O. A. Carretero Depolarization of the macula densa induces superoxide production via NAD(P)H oxidase Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1867 - F1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Hong and J. L. Garvin Flow increases superoxide production by NADPH oxidase via activation of Na-K-2Cl cotransport and mechanical stress in thick ascending limbs Am J Physiol Renal Physiol, March 1, 2007; 292(3): F993 - F998. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Krotz, M. Keller, S. Derflinger, H. Schmid, T. Gloe, F. Bassermann, J. Duyster, C. D. Cohen, C. Schuhmann, V. Klauss, et al. Mycophenolate Acid Inhibits Endothelial NAD(P)H Oxidase Activity and Superoxide Formation by a Rac1-Dependent Mechanism Hypertension, January 1, 2007; 49(1): 201 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hidalgo, G. Sanchez, G. Barrientos, and P. Aracena-Parks A Transverse Tubule NADPH Oxidase Activity Stimulates Calcium Release from Isolated Triads via Ryanodine Receptor Type 1 S -Glutathionylation J. Biol. Chem., September 8, 2006; 281(36): 26473 - 26482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oelze, A. Warnholtz, J. Faulhaber, P. Wenzel, A. L. Kleschyov, M. Coldewey, U. Hink, O. Pongs, I. Fleming, S. Wassmann, et al. NADPH Oxidase Accounts for Enhanced Superoxide Production and Impaired Endothelium-Dependent Smooth Muscle Relaxation in BK{beta}1-/- Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1753 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Hordijk Regulation of NADPH Oxidases: The Role of Rac Proteins Circ. Res., March 3, 2006; 98(4): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Yi, V. X. Li, F. Zhang, F. Yi, D. R. Matson, M. T. Jiang, and P.-L. Li Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1136 - H1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qin, T. Nagao, I. Grosheva, F. R. Maxfield, and L. M. Pierini Elevated Plasma Membrane Cholesterol Content Alters Macrophage Signaling and Function Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 372 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. McCarty and K. I. Block Multifocal Angiostatic Therapy: An Update Integr Cancer Ther, December 1, 2005; 4(4): 301 - 314. [Abstract] [PDF] |
||||
![]() |
K. Szaszi, G. Sirokmany, C. D. Ciano-Oliveira, O. D. Rotstein, and A. Kapus Depolarization induces Rho-Rho kinase-mediated myosin light chain phosphorylation in kidney tubular cells Am J Physiol Cell Physiol, September 1, 2005; 289(3): C673 - C685. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Krotz, B. Engelbrecht, M. A. Buerkle, F. Bassermann, H. Bridell, T. Gloe, J. Duyster, U. Pohl, and H.-Y. Sohn The Tyrosine Phosphatase, SHP-1, Is a Negative Regulator of Endothelial Superoxide Formation J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1700 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Papaharalambus, W. Sajjad, A. Syed, C. Zhang, M. O. Bergo, R. W. Alexander, and M. Ahmad Tumor Necrosis Factor {alpha} Stimulation of Rac1 Activity: ROLE OF ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE J. Biol. Chem., May 13, 2005; 280(19): 18790 - 18796. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamaguchi, Y. Tomiyama, T. Katayama, H. Kitahata, and S. Oshita Involvement of Adenosine Triphosphate-Sensitive Potassium Channels in the Response of Membrane Potential to Hyperosmolality in Cultured Human Aorta Endothelial Cells Anesth. Analg., February 1, 2005; 100(2): 419 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Matsuzaki, S. Chatterjee, K. DeBolt, Y. Manevich, Q. Zhang, and A. B. Fisher Membrane depolarization and NADPH oxidase activation in aortic endothelium during ischemia reflect altered mechanotransduction Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H336 - H343. [Abstract] [Full Text] [PDF] |
||||
|
|